OPLI up 4% 02-23-2012 FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma http://www.biomedreports.com/2012022389950/fda-grants-orphan-drug-status-for-cf102-for-the-treatment-of-hepatocellular-carcinoma-to-can-fite-biopharma.html